inmediQ
Butzbach, Germany
inmediQ is focused on modern heart and vascular analysis, primarily through their innovative product called VasioCore®. This technology provides advanced cardiovascular intelligence, allowing healthcare professionals to visualize vascular parameters, analyze cardiac performance, and track changes over time due to lifestyle modifications or treatments. Their systems detect structural changes in the cardiovascular system and identify hidden risks by analyzing factors like arterial resistance and blood flow properties. Utilizing a patented digital model called the Cardiovascular Twin, VasioCore® offers individual analyses with an accuracy of 99.98%, making it a superior alternative to traditional pulse wave analysis. The device is non-invasive and aims to support preventive strategies for healthy longevity.
Company Info
- Founded
- 2020
- Website
- inmediq.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of inmediQ?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.